Source link : https://newshealth.biz/health-news/pcsk9-inhibitors-linked-to-better-survival-in-some-cancer-patients-on-immunotherapy/
Strong preclinical evidence suggested PCSK9 inhibitors may overcome immunotherapy resistance by preventing tumor cells from evading the immune system. In patients with lung cancer, melanoma, or kidney cancer, use of PCSK9 inhibitors, in addition to immunotherapy, was associated with better survival in this matched-cohort study. The survival benefit was independent of cardiovascular outcomes, suggesting an […]
The post PCSK9 Inhibitors Linked to Better Survival in Some Cancer Patients on Immunotherapy first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-29 20:35:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8